T Cell News and Research

Latest T Cell News and Research

Scientists invent novel low-viscosity gel for regenerating human tissue

University of Delaware scientists have invented a novel biomaterial with surprising antibacterial properties that can be injected as a low-viscosity gel into a wound where it rigidifies nearly on contact--opening the door to the possibility of delivering a targeted payload of cells and antibiotics to repair the damaged tissue.

19 Jul 2007

PET scans show if radiation is shrinking lung tumors

Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked.

19 Jul 2007

Smart devices in health care

What people have come to expect in cell phones and personal communicators may soon become common in health-care devices and products at home and in medical offices, thanks to new technology announced by the University of Florida and IBM.

19 Jul 2007

Discovery of gene variant that increases risk for Crohn's disease

Pediatrics researchers have identified a gene variant that raises a child's risk of Crohn's disease, a chronic and painful condition attributed to inflammation of the gastrointestinal tract.

19 Jul 2007

Protein kinase G holds promise for cancer treatment

An enzyme that cancer cells eliminate, apparently so they can keep proliferating, may hold clues to more targeted, effective cancer treatment, scientists say.

19 Jul 2007

Researchers pinpoint brain region linked to placebo effect

Researchers have pinpointed a brain region central to the machinery of the placebo effect, the often controversial phenomenon in which a person's belief in the efficacy of a treatment such as a painkilling drug influences its effect.

19 Jul 2007

Researchers identify gene-regulating protein in the brain that triggers ability to cope with

Researchers have identified a gene-regulating protein in the brains of mice that triggers the animals' ability to cope with the "behavioral despair" caused by inescapable stress.

19 Jul 2007

Preconditioning protects brain from stroke

Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill Cornell Medical College in New York City.

18 Jul 2007

Wearable cardiac telemedicine system

A Bluetooth heart monitor could text your local hospital if you are about to have a heart attack, according to research published today in Inderscience's International Journal of Electronic Healthcare.

18 Jul 2007

Suicide gene therapy for cancer

Cutting-edge research at South Dakota State University may yield a new therapy that targets only cancer cells, leaving healthy cells unharmed.

18 Jul 2007

Chemotherapy before surgery appears better than surgery alone for nonsmall cell lung cancer

Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6% compared with surgery alone.

18 Jul 2007

Orange juice healthy for diabetics

Orange juice, despite its high caloric load of sugars, appears to be a healthy food for diabetics due to its mother lode of flavonoids, a study by endocrinologists at the University at Buffalo has shown.

18 Jul 2007

Heart patches that stimulate regeneration

When human hearts are injured, as during a heart attack, healthy tissue normally can't regrow.

18 Jul 2007

Coping with empty-nest syndrome

Your high school graduate is off to college to embark on a newly independent life.

18 Jul 2007

Insights into side effects of HIV protease inhibitors

UCLA scientists, along with collaborators from Purdue University, have demonstrated that HIV protease inhibitors, crucial drugs for HIV treatment block a cellular enzyme important for generating the structural scaffolding for the cell nucleus.

17 Jul 2007

Protein km23 - potential target for ovarian cancer treatment

A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth.

17 Jul 2007

Biota and MedImmune announce clinical trial for respiratory syncytial virus antiviral drug

Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.

17 Jul 2007

Cutaneous T-cell lymphoma becomes more common in U.S.

The cancer known as cutaneous T-cell lymphoma became substantially more common in the United States between 1973 and 2002, according to a report in the July issue of Archives of Dermatology.

17 Jul 2007

Researchers identify new combination therapy that promotes cancer cell death

Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials They propose that the therapy may help to selectively eliminate cancer cells while leaving healthy cells intact, providing a cancer treatment with fewer side effects.

17 Jul 2007

New hope for childhood cancer sufferers

Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.

17 Jul 2007